Testing effectiveness (Phase 2)Study completedNCT02936479
What this trial is testing
C1-Inhibitor (INH) for Refractory Antibody Mediated Renal Allograft Rejection
Who this might be right for
Antibody Mediated Rejection of Kidney Transplant
NYU Langone Health 1